A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: LY2835219|DRUG: Letrozole|DRUG: Anastrozole|DRUG: Tamoxifen|DRUG: Exemestane|DRUG: Everolimus|DRUG: Trastuzumab|DRUG: LY3023414|DRUG: Fulvestrant|DRUG: Pertuzumab|DRUG: Loperamide|DRUG: Endocrine therapy
Sponsor: Eli Lilly and Company